THYMOSIN ALPHA-1
(Tα1)
Thymosin Alpha-1 (Tα1) is a powerful immune-modulating peptide with exceptional benefits for life longevity and overall health. It enhances immune system function by promoting T-cell activity, increasing natural killer (NK) cell response, and modulating inflammation. This peptide plays a key role in defending against infections, cancer, and age-related immune decline. Thymosin Alpha-1 also improves the body’s resistance to oxidative stress and supports tissue regeneration. Its immune-boosting and anti-inflammatory effects make it valuable in combating chronic illness and slowing biological aging. With consistent, supervised use, Thymosin Alpha-1 may help extend healthspan, reduce disease risk, and promote long-term vitality and resilience.
Benefits
Immune System Enhancement
​
-
Boosts T-cell production and function
-
Increases natural killer (NK) cell activity
-
Improves response to viruses, bacteria, and tumors
-
Supports vaccine response, especially in older adults
Anti-Aging and Longevity Support
​
-
Counters age-related immune decline (immunosenescence)
-
Helps maintain immune homeostasis in aging individuals
-
Supports longer healthspan by reducing disease burden
Anti-Inflammatory Effects
​
-
Regulates cytokines to reduce chronic inflammation (a hallmark of aging)
-
Balances pro- and anti-inflammatory responses
Antiviral and Anticancer Properties
​
-
Used as an adjuvant in cancer and chronic viral infections (HIV, hepatitis, HPV)
-
May inhibit cancer cell proliferation and metastasis
Supports Tissue Repair and Regeneration
​
-
Encourages healing and cell recovery after illness or injury
-
May aid in organ protection and recovery from oxidative stress
Enhances Resilience and Recovery
​
-
Improves recovery time from illness, surgery, or immunocompromised states
-
May protect against immune burnout from chronic stress or toxins
Side Effects
Mild and Common Side Effects
​
-
Injection site reactions
-
Redness, swelling, itching, or pain
-
-
Fatigue or low energy (usually temporary)
-
Headache
-
Mild flu-like symptoms (especially during initial use)
Less Common or Rare Side Effects
​
-
Nausea or gastrointestinal discomfort
-
Dizziness or light-headedness
-
Dry mouth or metallic taste
-
Temporary skin rash or irritation
-
Mood changes (e.g., anxiety or mild irritability)
Theoretical or Unconfirmed Risks
​
-
Unknown effects with long-term use (studies mostly short- to mid-term)
-
Should be used cautiously in autoimmune disorders unless under medical supervision
-
Not recommended during pregnancy or breastfeeding without physician approval
Safety Notes
​
-
Thymosin Alpha-1 has been used in clinical settings (including in cancer and viral infection therapy) with a strong safety profile
-
Always use pharmaceutical-grade peptides from reputable sources
-
Monitor for adverse effects during the first few days of use
Dosage
Standard Injectable (Subcutaneous)
Typical Longevity/Wellness Protocol
​
-
Dose: 1.0 to 1.5 mg
-
Frequency: 2–3 times per week
-
Route: Subcutaneous injection, preferably in the abdomen or upper thigh
-
Cycle: 4–8 weeks on, followed by a 4–8 week break, or as advised by a physician
-
Maintenance: Optional lower dose (e.g., 1 mg weekly) after initial cycles
Clinical/Immune Support Protocols (e.g., cancer, viral infections)
​
-
Dose: 1.6 mg daily (divided or single dose)
-
Duration: Often 2–6 weeks, under medical supervision
-
Used in combination with other therapies for more advanced cases
Alternative Routes (Less Common)
​
-
Intramuscular injection (used in some clinical settings)
-
Not effective orally or sublingually due to poor bioavailability
Precautions
​
-
Do not exceed 6 mg/week without medical supervision
-
Avoid during pregnancy or breastfeeding unless approved by a physician
-
Always use sterile technique and pharmaceutical-grade peptides
Tips:
-
Store peptide in the refrigerator (2–8°C) once reconstituted.
-
Use bacteriostatic water for reconstitution.
-
Always follow aseptic injection protocols.​
Medical Disclaimer: These guidelines are for educational purposes only. Always consult a licensed medical professional before starting any peptide therapy.